𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Societal cost savings through bevacizumab-based treatment in non-small cell lung cancer (NSCLC)

✍ Scribed by Stanisic, Sanja; Bischoff, Helge G.; Heigener, David F.; Vergnenègre, Alain; de Castro Carpeño, Javier; Chouaid, Christos; Walzer, Stefan; Mueller, Elvira; Schmidt, Elvira


Book ID
118574645
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
197 KB
Volume
69
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES